Brainsway

Yahoo Finance • 9 days ago

BrainsWay Announces Minority-Stake Investment in Hopemark Health

BURLINGTON, Mass. and JERUSALEM, Israel, May 18, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorder... Full story

Yahoo Finance • 14 days ago

Brainsway Q1 Earnings Call Highlights

Brainsway logo Key Points Interested in Brainsway Ltd. Sponsored ADR? Here are five stocks we like better. BrainsWay posted strong Q1 results with revenue up 35% year over year to $15.5 million, its 11th straight profitable quarter, and... Full story

Yahoo Finance • 14 days ago

BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights

Revenue grew approximately35% year-over-year to$15.5 million for Q1 2026 Net income increased by over 100% year-over-year to $2.3million for Q1 2026 Adjusted EBITDA for Q1 of 2026 more than doubled year-over-year to $2.8 million Remaini... Full story

Yahoo Finance • 28 days ago

BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026

BURLINGTON, Mass. and JERUSALEM, April 29, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation technologies, today announced that it will... Full story

Yahoo Finance • 2 months ago

Midday Fly By: IEA to release 400M oil barrels, Oracle reports Q3 beat

The major averages were lower near noon, with the Dow dropping over 400 points as traders weigh shifting oil prices and a key inflation report. Markets are trading cautiously amid volatile energy prices and ongoing geopolitical tensions in... Full story

Yahoo Finance • 3 months ago

BrainsWay at an all-time high on Q4 beat, upside guidance

[Close up image of wooden cubes with alphabet Q4 on office desk.] mohd izzuan BrainsWay (BWAY [https://seekingalpha.com/symbol/BWAY]) shares added ~10% on Wednesday to reach an all-time high after the Israeli MedTech firm reported better-... Full story

Yahoo Finance • 3 months ago

Landmark Data Validate BrainsWay’s SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment

BURLINGTON, Mass. and JERUSALEM, March 04, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) unveiled new clinical data showing a significantly faster, noninvasive way to treat depression without compromising the efficacy of... Full story

Yahoo Finance • 5 months ago

BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™

BrainsWay Optum Behavioral Health, a Health Services Company with Over 48 Million Covered Lives, Joins Growing List of Insurers Now Covering Deep TMS Depression Therapy for Adolescents Aged 15 and Older BURLINGTON, Mass. and JERUSALEM, D... Full story

Yahoo Finance • 6 months ago

BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company’s Growth Strategy and Deep TMS™ Treatment December 1, 2025

BURLINGTON, Mass. and JERUSALEM, Nov. 25, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced that it will... Full story

Yahoo Finance • 6 months ago

BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder

BURLINGTON, Mass. and JERUSALEM, Nov. 17, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced the launch of... Full story

Yahoo Finance • 6 months ago

BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21

BURLINGTON, Mass. and JERUSALEM, Israel, Nov. 13, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorde... Full story

Yahoo Finance • 6 months ago

Here are the major earnings before the open Tuesday

Major earnings expected before the bell on Tuesday include: * Nebius Group N.V. (NBIS [https://seekingalpha.com/symbol/NBIS]) * Sea Limited (SE [https://seekingalpha.com/symbol/SE]) * Workhorse Group (WKHS [https://seekingalpha.com/... Full story

Yahoo Finance • 7 months ago

BrainsWay Q3 2025 Earnings Preview

* BrainsWay (BWAY [https://seekingalpha.com/symbol/BWAY]) is scheduled to announce Q3 earnings results on Tuesday, November 11th, before market open. * The consensus EPS Estimate is $0.04 [https://seekingalpha.com/symbol/BWAY/earnings/... Full story

Yahoo Finance • 7 months ago

BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025

BURLINGTON, Mass. and JERUSALEM, Oct. 28, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, toda... Full story

Yahoo Finance • 7 months ago

BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers

Recent agreements withtwo additional U.S. mental health providersbring total to four in 2025 Strategy seeks to drive long-term shareholder value BURLINGTON, Mass. and JERUSALEM, Oct. 27, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ... Full story

Yahoo Finance • 9 months ago

Brainsway stock maintains Buy rating at H.C. Wainwright after strategic investments

Investing.com - H.C. Wainwright has reiterated a Buy rating and $17.00 price target on Brainsway (NASDAQ:BWAY), the $288 million market cap medical device company that has delivered an impressive 61% return year-to-date. According to Inves... Full story

Yahoo Finance • 9 months ago

BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.

This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home Neurolief’s breakthrough Proliv™Rx device is pending Premarket Approval from the U.S. F... Full story

Yahoo Finance • 9 months ago

BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health

BURLINGTON, Mass. and JERUSALEM, Aug. 20, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, toda... Full story

Yahoo Finance • 9 months ago

BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights

Achieved record quarterly revenue of $12.6 million in Q2 2025, an increase of 26% compared to Q2 2024 Operating profit totaled $0.6 million and Adjusted EBITDA rose to $1.5 million, Raised full-year 2025 Revenue and EBITDA guidance Rema... Full story

Yahoo Finance • 9 months ago

S&P Futures Gain as Fed Rate-Cut Bets Firm

September S&P 500 E-Mini futures (ESU25 [https://www.barchart.com/futures/quotes/ESU25]) are trending up +0.24% this morning, extending yesterday’s gains as growing expectations for Federal Reserve interest rate cuts fueled risk-on sentime... Full story